Novel disease biomarkers for newborn epilepsy screening
It is now possible to screen newborn babies for pyridoxine-dependent epilepsy (PDE), a severe inherited metabolic disorder. This screening promises to enable better and earlier treatment of the disease. To identify new biomarkers ...
Jul 8, 2021
0
2